← All trials
NCT02431273
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2015
- Primary completion
- Dec 1, 2016
- Completion date
- Dec 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 6
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Auritec PharmaceuticalsLead sponsor
- University of Texas, GalvestonOverall official - principal investigator
- University of Texas, GalvestonCollaborator
- Oak Crest Institute of ScienceCollaborator
- National Institutes of Health (NIH)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.